About this On Demand Training

What's New in the World of Antibiotic Stewardship? Part One: Using Performance Measures in Practice to Drive Change

For HEDIS Measurement Year 2022,  NCQA released the Antibiotic Utilization for Respiratory Conditions measure. The measure can help health plans more closely monitor antibiotic use and assist with stewardship efforts. It tracks antibiotic prescriptions across both appropriate and inappropriate respiratory conditions. Tracking antibiotic prescribing for all respiratory conditions will provide context about a health plan’s overall antibiotic use when viewed with three HEDIS measures of appropriate testing and inappropriate prescribing.

Dr. Eddie Stenehjem, Senior Medical Director of Medical Specialties and past Medical Director of Antimicrobial Stewardship at Intermountain Healthcare, will join NCQA to describe Intermountain’s ambulatory antibiotic stewardship platform and how Intermountain monitors antibiotic utilization to support antibiotic stewardship efforts. 

The purpose of this session is to provide an overview of the new HEDIS antibiotic measure and highlight its use in the field. Participants will be able to ask questions of researchers to learn directly from them about their work. 

What You Will Learn

• Review the new HEDIS antibiotic measure: Antibiotic Utilization for Respiratory Conditions.
• Review the use of antibiotic measures in practice.
• Discuss researcher/expert studies and results regarding antibiotic stewardship.

Who Should Attend

• Health care professionals 
• Health care decision makers 
• Consultants 
• Health plans 
• Health systems 
• Health centers/health practices 
• Hospitals 
• Population health organizations 
• Federal and state government agencies

Faculty

Sepheen Byron, DRPH, MHS

Sepheen Byron is Assistant Vice President, Performance Measurement, at the National Committee for Quality Assurance (NCQA). She oversees measure development and use of HEDIS and other national evaluation programs and has developed measures used by NCQA for Accreditation, benchmarking and ratings. She also led measure development for Medicaid and CHIP enrollees as part of NCQA’s AHRQ-CMS Pediatric Quality Measures Program Center of Excellence. Ms. Byron is the subject matter expert for measures in the area of antibiotic stewardship, and recently led a project to broaden HEDIS antibiotic measures to additional populations.

Prior to NCQA, Ms. Byron was an Analyst in the Center for Outcomes and Evidence at the Agency for Healthcare Research and Quality, where she assessed the effectiveness of health services.

Ms. Byron has a BA from the University of Virginia, an MHS from the Johns Hopkins University Bloomberg School of Public Health, and a DrPH from the Gillings School of Global Public Health, University of North Carolina at Chapel Hill.

Eddie Stenehjem, MD, MSc

Dr. Edward (Eddie) Stenehjem is an Infectious Diseases physician and Intermountain Healthcare’s Senior Medical Director of Medical Specialties, leading 11 medical specialties for the enterprise in best practice implementation and operations.  Dr. Stenehjem served as Intermountain’s first Medical Director of Antimicrobial Stewardship from 2018 through April 2021.  During that time, he led antimicrobial stewardship programs across 23 hospitals and over 185 outpatient clinics throughout Utah and Idaho.  His research is focused on improving the quality of care delivered to patients with an emphasis on developing, implementing, measuring, and communicating methods of improvement across the continuum of care.  More recently, Dr. Stenehjem has been deeply engaged in Intermountain’s COVID response and community advocacy along with vaccine effectiveness research.  Dr. Stenehjem has served on multiple national committees and has represented Intermountain Healthcare at the United Nations, the CDC, and the White House. 

Continuing Education

In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide Interprofessional Continuing Education for the healthcare team. 

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

This educational activity is approved for a maximum of 1.0 AMA PRA Category 1 Credit™. 

This educational activity is approved for 1.0 nursing contact hours.*

The assigned universal program number:JA0004597-0000-22-031-H04-P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.

This live course grants 1.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.  

Disclosure of Relevant Financial Relationships

The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.

For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution.  For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant financial relationships exist with the following companies/organizations:

Faculty:
Eddie Stenehjem: Dr. Stenehjem is funded by the Centers for Disease Control and Prevention Shepherd Contract (no. 200-2016-91799).

Sepheen Byron: Dr. Byron received funding from the Centers for Disease Control and Prevention (contract no. 75D30120C08243) to develop the measure related to antibiotic utilization.

Additional Planning Committee Members:
Tammy Cox: None 
Cathy Beckner: None
Nancy McGee: None
Tracelyn Thigpen: None
Sepheen Byron: Dr. Byron received funding from the Centers for Disease Control and Prevention (contract no. 75D30120C08243) to develop the measure related to antibiotic utilization.

This program was developed in part by NCQA staff.

Acknowledgement
Support for this project was provided by The Pew Charitable Trusts.

Disclaimer
“The views expressed are those of the author(s) and do not necessarily reflect the views of The Pew Charitable Trusts”.

* Please note – You must attend the entire program to be eligible for total number of contact hours.